Introduction
============

Inflammatory bowel disease, including Crohn's disease (CD) and ulcerative colitis (UC), is a chronic, relapsing and non-specific inflammatory disease with an unknown etiology ([@B20]). Typical clinical manifestations of IBD include abdominal pain, diarrhea, and bloody mucopurulent stool. In China, the incidence and prevalence of IBD has significantly increased in recent years, which is probably due to an industrialized and westernized lifestyle, such as a high fat diet and an increase in intake of sugars, cigarette smoking, mental stress, antibiotics usage, and an imbalance of the intestinal flora ([@B39], [@B40]). First-line treatments for IBD involve the use of immunosuppressants, corticosteroids, and anti-tumor necrosis factor (TNF) antibodies. Although these conventional methods may to some extent alleviate clinical symptoms, drug adverse reactions and high therapy-associated costs have been widely reported ([@B31]). In recent years, herbal therapies, including Huangqin-Tang, aloe vera gel, extract of *Serpylli herba*, *Artemisia absinthium*, *Tripterygium wilfordii*, and *Andrographis paniculata* have shown beneficial effects in IBD patients ([@B26]).

Etiological studies have demonstrated that an aberrant immune response, genetic factors, and aberrations in the epithelial barrier and gut microbiota play important roles in the pathogenesis of IBD ([@B41]). Gut microbiota play a crucial role in triggering, maintaining, and exacerbating IBD ([@B7]). IBD is linked to a lack of physiological tolerance of the mucosal immune system to resident gut microbiota and pathogens ([@B27]). A reduction in bacterial diversity as well as a greater bacterial instability have been observed in patients with IBD. Increasing evidence has shown that overexpression of potentially proinflammatory microbes were exhibited in 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced IBD rats. Moreover, it has been extensively reported that a decreased abundance of Firmicutes and Bacteroidetes, and an increased abundance of Proteobacteria were related to the severity of IBD ([@B8]; [@B28]). In addition, *Clostridium* clusters XIVa and IV consisting of *Clostridium*, *Ruminococcus*, *Lachnospira*, *Roseburia*, *Coprococcus*, *Eubacterium*, as well as *Anaerofilum* genera, and *Faecalibacterium prausnitzii* (*F. prausnitzii*), which belong to phylum Firmicutes, are reduced in IBD patients ([@B11]).

Intestinal immune system disorder is regarded as another main pathogenesis during the progression of IBD. In IBD rats, an imbalance between CD4^+^ T helper (Th) cells and regulatory CD4^+^ T (Treg) cells, which may further damage the pro/anti-inflammatory cytokine balance, has been reported ([@B44]). Therefore, immune-related inflammatory cytokines and Tregs are frequently-used targets for the treatment of IBD ([@B38]; [@B10]).

*Amomum villosum* Lour. (Zingiberaceae, a legal source plant of Amomi Fructus) is a classic traditional Chinese herbal plant ([@B4]). Previous pharmacological studies have shown that Amomi Fructus has great anti-ulceration, anti-diarrhea, anti-inflammatory, and antimicrobial activities ([@B14]). In our previous study, we demonstrated that *A. villosum* prevented the development and progression of intestinal mucositis after chemotherapy ([@B43]). In this previous study, we found that *A. villosum* significantly alleviated endoenteritis by downregulating p38 MAPK and caspase-3 expression, strengthened the intestinal mucosal barrier, reduced the number of pathogenic bacteria, and increased the abundance of probiotics. Although *A. villosum* has been widely used in the treatment of gastrointestinal diseases, whether *A. villosum* can be applied in the treatment of IBD and its possible mechanisms of action involved are still lacking. In this study, we explored the effects of water extract and volatile oil of *A. villosum* on CD4^+^ T cells, immune homeostasis, and gut microbiota balance in a TNBS-induced colitis rat model.

Materials and Methods {#s1}
=====================

Preparation of Water Extract and Volatile Oil From *A. villosum*
----------------------------------------------------------------

Fruit from *A. villosum* Lour. was collected in the Jingping County, Honghe Prefecture of Yunnan Province, China. Plants were identified as *A. villosum* Lour. by Jie Yu, an Associate Professor at Yunnan University of Traditional Chinese Medicine. Voucher specimens were deposited in the Herbarium of Pharmacognosy, Yunnan University of Traditional Chinese Medicine.

*A. villosum* fruit (400 g) was minced to powder and soaked in 3 L of water for 30 min at room temperature, then decocted three times with 3, 2, and 1 L of water, for 30 min each, respectively. Extracts were combined, condensed, and lyophilized. The water extraction yield of *A. villosum* (WEAV) was 14% of the crude drug.

Another 400 g of powdered sample of *A. villosum* was soaked in 3 L water for 30 min at room temperature. Volatile oil was extracted by steam distillation for 5 h, then dried with anhydrous sodium sulfate. The volatile oil yield of *A. villosum*(VOAV) was 3.6% of the crude drug.

Animals
-------

Adult male Sprague-Dawley rats weighing between 200 and 250 g were purchased from Da Shuo Biotech Co., Ltd., China (Certificate number SCXK 2013-24, Chengdu, China). Rats were kept on standard rat chow and water *ad libitum*, and were adaptively acclimatized for 7 days, with a 12 h light/dark cycle, a temperature of 23°C, and a 60% humidity. Experiments were performed in accordance with the guidelines of the Institutional Ethical Committee on Animal Care and Experimentations of Yunnan University of Traditional Chinese Medicine (R-0620160016). Surgeries were performed using sodium pentobarbital anesthesia and all efforts were made to minimize suffering of the rats.

Induction of IBD and Treatment
------------------------------

Rats were fasted for 48 h with free access to water and anesthetized with 3% sodium pentobarbital (50 mg/kg). Next, colitis was induced according to the methods described by [@B29]. In brief, a lavage needle was inserted into the anus of each rat and the tip of the needle was advanced to 8 cm proximal to the anus verge. Next, a 5% TNBS solution (100 mg/kg) (Xiya Reagent, Chengdu, China) was dissolved in 0.25 mL 50% ethanol, and was injected into the colon. Rats in the control group were injected with 0.9% saline. After injection, all rats were kept in a head-down position for 1 min to avoid leakage of TNBS solution, then laid flat until consciousness was regained.

A total of 90 rats were randomly divided into nine groups (10 rats per group), including a control (CON) group; model (MOD) group; low-, medium-, and high-dose of WEAV (WEAV.L, WEAV.M, and WEAV.H) groups; low-, medium-, and high-dose of VOAV (VOAV.L, VOAV.M, and VOAV.H) groups; mesalazin enteric-coated tablets (MES) group (Sunflower Pharmaceutical Group Jiamusi Luling Pharmaceutical Co., Ltd., Haerbin, China). Rats in the CON and MOD group were gavaged with water. Rats in the WEAV.L, WEAV.M, and WEAV.H groups were orally administered with 200, 400, and 800 mg/kg dose of WEAV, respectively. Moreover, rats in the VOAV.L, VOAV.M, and VOAV.H groups were orally administered with 7, 14, and 28 mg/kg VOAV, respectively. Rats in the MES group were orally administered with mesalazin at 360 mg/kg. The concentrations of VOAV and WEAV were chosen from human clinical dosages of *A.villosum*, which were recommended by [@B4]. The middle dose for humans was calculated as 4.5 g/kg in this study, and the rats dosages used were converted from the human dosage listed according to the body surface area. In addition, the yield of WEAV and VOAV were also considered. Treatments were started 6 h after IBD induction and continued for 9 consecutive days. Food intake and body weight were recorded daily.

Disease Activity Index
----------------------

Disease Activity Index (DAI) was measured according to a previously described method with some modifications ([@B23]). Scores were given based on the percentage of weight loss (0, none; 1, 1--5%; 2, 5--10%; 3, 10--15%; and 4, \>15%), stool consistency (0, normal; 1, pasty stool that does not stick to the anus; 2, pasty stool that does not stick to the anus; 3, pasty stool that stuck to the anus; and 4, watery stool), and rectal bleeding (0, hemoccult (-); 1, hemoccult (±); 2, hemoccult (+); 3, hemoccult (++); and 4, obvious blood in stool).

Assessment of Colonic Damage
----------------------------

Rats were anesthetized with 3% sodium pentobarbital on day 9. The entire colon was removed and the length was measured. Then, colons were cut longitudinally along the mesentery, washed with ice-cold saline, and weighed. Macroscopic damage was scored according the method described by [@B2] with modifications as follows: 0, no ulcers and inflammation; 1, mucosal hyperemia and edema; 2, ulceration without mucosal hyperemia and edema; 3, single ulceration and mucosal inflammation; 4, more ulceration and mucosal inflammation; and 5, severe ulceration extending \>2 cm along colon length, mucosal hyperemia and edema.

Of each group, three representative samples were selected, fixed in 10% formalin and stained with hematoxylin and eosin (HE, submittal for inspection). The histological scores were assessed according to a method described by [@B25]. Scores were as follows: 0, no colonic tissue damage; 1, low level of inflammatory cell infiltration, intestinal villus arranged neatly; 2, medium level of inflammatory cell infiltration, crypt damage, bowel wall thickening without invasion of the muscular layer; 3, high level of inflammatory cell infiltration, vascular proliferation, bowel wall thickening with an invaded muscular layer; 4, inflammatory cell infiltration, loss of goblet cells, vascular proliferation, and bowel wall thickening with an invaded muscular layer.

Assessment of Th1-, Th2-, Th17-, and Treg-Related Cytokine Expression in Blood Samples and Colonic Tissue
---------------------------------------------------------------------------------------------------------

From all rats, blood and colonic tissue samples were collected at the end of the experiment. The blood sample for assessment of Th1-, Th2-, Th17-, and Treg-related cytokine expressions were collected from rat retrobulbar venous plexus. Colonic tissue (100 mg) was homogenized in 1 mL 1× PBS and stored overnight at -20°C. Two freeze--thaw cycles were performed to break the cell membranes. Next, samples were centrifuged for 10 min at 10,000 rpm at 4°C to obtain serum and colonic tissue supernatants. Serum levels of IL-17, TGF-β, and IL-10 were determined using ELISA kits (Cusabio Biotech Co., Ltd., Wuhan, China). Levels of MPO, IFN-γ, and TNF-α in colonic tissue supernatants were analyzed by ELISA kits (Cusabio Biotech Co., Ltd., Wuhan, China). All assays were carried out using a Spectra Max PLUS 384 enzyme microplate reader (Molecular Devices Corporation, United States).

Flow Cytometry Measurement of CD4^+^CD25^+^Foxp3^+^ Treg Cells
--------------------------------------------------------------

For analysis of Treg cells, rat spleens were grinded and washed with RPMI 1640 medium (Sigma, Germany) to obtain a single cell suspension. Then, cells were incubated with fluorescein isothiocyanate (FITC)-labeled anti-CD4 and phycoerythrin (PE)-labeled anti-CD25 antibodies for 25 min at 37°C. Cells were fixed and permeabilized with Fix/Perm solution. Cells were then washed in PBS and intracellular staining was performed using an allophycocyanin (APC)-labeled anti-Foxp3 antibody. Cells (1 × 10^6^) were resuspended in 500 μL flow cytometry staining buffer and analyzed using a FACSCalibur (Becton, Dickinson, Company, United States). Antibodies and the buffer used for analysis of Treg cells were purchased from eBioscience (San Diego, CA, United States).

Assessment of Portal Vein Endotoxin Levels
------------------------------------------

Hepatic portal vein blood samples were collected from sodium pentobarbital anesthetized rats using disposable vacuum blood collection tubes. Blood samples were centrifuged for 10 min at 4000 rpm and 4°C. Lipopolysaccharide (LPS) concentrations in plasma were determined using a tachypleus amebocyte lysate test purchased from Chinese Horseshoe Crab Reagent Manufactory, Co., Ltd., Xiamen, China.

Amplification and Sequencing of the 16S rDNA Gene
-------------------------------------------------

From the rats in each group, stool samples were collected using a 1.5 mL of sterilized cryogenic vials and stored at -80°C. From each group, three stool samples (100 mg each) were randomly chosen, weighed, and DNA was extracted using a stool mini kit (Omega Bio-tek, Norcross, GA, United States). The colony diversity in the colon, and the overall structural changes in gut microbiota were subjected to pyrosequencing of V4 regions of 16S rDNA, and amplified by PCR amplification using a 515F-806R primer set.

Statistical Analysis
--------------------

Statistical analysis was performed using SPSS version 19 software. Non-parametric data were analyzed by Wilcoxon rank sum test and multiple comparison for *post-hoc* test for significant pairwise differences. Parametric data were analyzed using one-way analysis of variance (ANOVA) with pairwise comparison as *post-hoc* test. *P* \< 0.05 were considered significant. The Pearson's correlation was conducted by SPSS statistics 19 software and graphics were prepared using Origin 6.1 software.

Results
=======

General Physiological Features
------------------------------

General physiological features of rats, including body weight, food intake, DAI scores, colon weight and colon length were documented. Rats in the MOD group showed significant loss in weight and appetite when compared with rats in the CON group (*p* \< 0.001). IBD rats also displayed higher DAI scores that were associated with higher incidences of diarrhea, rectal bleeding, and increased colon weight/length ratio. VOAV.M and VOAV.H significantly prevented weight and appetite loss in IBD rats (*p* \< 0.05 or *p* \< 0.001) (**Figures [1A,B](#F1){ref-type="fig"}**). Compared with rats in the MOD group, the DAI scores of rats in all treatment groups were significantly decreased (**Figure [1C](#F1){ref-type="fig"}**). In addition, treatment with VOAV.M, VOAV.H, and WEAV.H was effective in reducing colon weight/length ratio (**Figure [1D](#F1){ref-type="fig"}**).

![Effects of *A. villosum* administration on general physiological features in TNBS-induced rats. **(A)** Gain of daily weight; **(B)** gain of daily food; **(C)** disease activity index; **(D)** colon weight/length ratio. Rats were induced with TNBS (100 mg/kg) in a 50% ethanol solution. Low, middle, and high doses of water extract (WEAV) and volatile oil of *A. villosum* (VOAV) were orally administered. On day 9 of treatment, rats were anesthetized and colons were harvested. Data are expressed as the mean ± SD (*n* = 10). The symbol "^∗^" indicates a significant difference compared with the model group, and "\#" indicates a significant difference compared with the control group. ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, ^∗∗∗^*p* \< 0.001, and ^\#\#\#^*p* \< 0.001.](fphar-09-00639-g001){#F1}

Macroscopic and Microscopic Assessment of the Colon
---------------------------------------------------

Macroscopic and microscopic scores of rats in the MOD group were significantly higher when compared to rats in the CON group (*p* \< 0.001). As shown in **Figure [2A](#F2){ref-type="fig"}**, ulceration with mucosal hyperemia and edema was observed in rats in the MOD group. Such changes were markedly improved by treatment with VOAV.H, VOAV.M, WEAV.H, or MES (*p* \< 0.01). Histological scoring revealed that all doses of VOAV, WEAV.M, and WEAV.H used in this study were effective in mitigating the severity of tissue lesions as characterized by the low level of inflammatory cell infiltration. Moreover, the intestinal villus arranged neatly and the number of goblet cells increased (*p* \< 0.01 or *p* \< 0.05, **Figure [2B](#F2){ref-type="fig"}**).

![Effects of *A. villosum* administration on macroscopic and histopathological changes in TNBS-induced rats. **(A)** Macroscopic appearance of colonic tissue (*n* = 10); **(B)** histopathological appearance of colonic tissue (*n* = 3, magnification ×100). Rats were induced by TNBS (100 mg/kg) in 50% ethanol solution. Various doses of VOAV and WEAV were orally administered. On the 9th day, rats were anesthetized and the colons were excised, fixed in 10% formalin and stained with hematoxylin and eosin. (A) Colon of CON group; (B) colon of MOD group; (C) colon of VOAV.H group; (D) colon of VOAV.M group; (E) colon of VOAV.L group; (F) colon of WEAV.H group; (G), colon of WEAV.M group; (H), colon of WEAV.L group; (I), colon of MES group. Data are expressed as the mean ± SD (*n* = 10 or *n* = 3). The symbol "^∗^" indicates a significant difference compared with the model group, and "\#" indicates a significant difference compared with the control group. ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, ^∗∗∗^*p* \< 0.001, and ^\#\#\#^*p* \< 0.001.](fphar-09-00639-g002){#F2}

Th1-, Th2-, Th17-, and Treg-Related Cytokine Expression
-------------------------------------------------------

ELISA assays were performed to evaluate the levels of MPO, Th17 signature cytokine IL-17, Th1 signature cytokine IFN-γ, and TNF-α, Th2, Treg-related cytokine IL-10, and TGF-β. In general, MPO activity is a measure of neutrophil infiltration, and treatment with both VOAV or WEAV had no significant effect on MPO activity when compared to rats in the MOD group (**Figure [3A](#F3){ref-type="fig"}**). Levels of pro-inflammatory cytokines IL-17, IFN-γ, and TNF-α were markedly increased in rats in the MOD group. Treatment with VOAV.H and WEAV.H resulted in a clearly reduction of IL-17 and TNF-α levels (*p* \< 0.05) by 41.6 and 36.8%, respectively (**Figures [3B,E](#F3){ref-type="fig"}**). Low and high-doses of VOAV and WEAV were effective in reducing IFN-γ levels (*p* \< 0.001, **Figure [3C](#F3){ref-type="fig"}**). When compared with rats in the MOD group, expression of anti-inflammatory cytokine IL-10 was significantly enhanced by 77.5, 76.3, and 77.5% in VOAV.H, VOAV.M, and WEAV.H groups, respectively (**Figure [3D](#F3){ref-type="fig"}**). Moreover, the level of anti-inflammatory cytokine TGF-β of WEAV and VOAV treatments was significantly higher compared to that of rats in the MOD group (*p* \< 0.001) (**Figure [3F](#F3){ref-type="fig"}**). These data suggested that treatment with VOAV and WEAV not only inhibited Th17 and Th1 responses, but also promoted Th2 and Treg responses in IBD.

![Effects of *A. villosum* administration on the expression of Th1-, Th2-, Th17-, and Treg-related cytokines in colonic tissue or serum of rats with IBD. **(A)** Colonic myeloperoxidase (MPO) activity; **(B)** serum Th17 signature cytokine IL-17; **(C)** colonic Th1 signature cytokine IFN-γ; **(D)** serum Th2 and Treg-related cytokine IL-10; **(E)** colonic Th1 signature cytokine TNF-α; **(F)** serum Treg-related cytokine TGF-β. Rats were induced by TNBS (100 mg/kg) in 50% ethanol solution. Various doses of VOAV and WEAV were orally administered. On the 9th day, blood and colonic tissue samples of all rats were collected and determined by ELISA. Data are expressed as the mean ± SD (*n* = 6). The symbol "^∗^" indicates a significant difference compared with the model group, and "\#" indicates a significant difference compared with the control group. ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, ^∗∗∗^*p* \< 0.001, and ^\#^*p* \< 0.05, ^\#\#\#^*p* \< 0.001.](fphar-09-00639-g003){#F3}

The Percentage of Regulatory CD4^+^ T Cells
-------------------------------------------

Foxp3^+^ is a key cellular transcriptional factor, which allows differentiation of naive T cells into Treg cells. In this study, the percentage of CD4^+^CD25^+^Foxp3^+^ Treg cells in the spleen was determined by flow cytometry. As shown in **Figure [4A](#F4){ref-type="fig"}**, the percentage of CD4^+^CD25^+^/CD4^+^T was 1.33% in rats in the CON group, compared with 0.89% in rats in the MOD group. Moreover, compared to rats in the MOD group, the ratio of CD4^+^CD25^+^/CD4^+^T among WEAV treated rats (*p* \< 0.001) was 6.88, 8.08, and 8.26%, respectively, compared with 1.92% in VOAV.L-treated rats (*p* \< 0.05). Our results also demonstrated that VOAV and WEAV treatment markedly increased the percentage of CD4^+^CD25^+^Foxp3^+^ Treg cells. WEAV treatment (3.45, 3.41, and 4.37%) (*p* \< 0.001) showed even better effects when compared to VOAV treatment (1.55, 1.39, and 1.85%) (**Figure [4B](#F4){ref-type="fig"}**). Thus, these findings indicated that the therapy of VOAV and WEAV on IBD may associated with activation of Treg cells.

![Effects of *A. villosum* administration on the percentage of CD4^+^CD25^+^Foxp3^+^ Treg cells. **(A)** Percentages of CD4^+^CD25^+^/CD4^+^ Treg cells; **(B)** Percentages of Foxp3^+^/CD4^+^CD25^+^ Treg cells. Rats were induced by TNBS (100 mg/kg) in 50% ethanol solution. Various doses of VOAV and WEAV were orally administered. On the 9th day, the Treg cells distribution in rat spleen were determined by flow cytometry. Data are expressed as the mean ± SD (*n* = 3). The symbol "^∗^" indicates a significant difference compared with the model group, and "\#" indicates a significant difference compared with the control group. ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, ^∗∗∗^*p* \< 0.001, and ^\#\#^*p* \< 0.01.](fphar-09-00639-g004){#F4}

Microbial Community Analysis
----------------------------

LPS, a cell-wall component of gram-negative pathogenic bacteria, is known to induce local or systemic non-special inflammatory lesions. The level of LPS in rats in the MOD group (0.11 ± 0.03 EU/mL) was significantly higher compared to that of rats in the CON group (0.05 ± 0.005 EU/mL) (*p* \< 0.05) (**Figure [5](#F5){ref-type="fig"}**). All VOAV and WEAV treatments showed a significant effect on inhibiting the increase of LPS (*p* \< 0.05), especially VOAV treatments.

![Effects of *A. villosum* administration on levels of lipopolysaccharide. Rats were induced by TNBS (100 mg/kg) in 50% ethanol solution. Various doses of VOAV and WEAV were orally administered. On the 9th day, hepatic portal vein blood samples of all rats were collected and determined by ELISA. Data are expressed as the mean ± SD (*n* = 6). The symbol "^∗^" indicates a significant difference compared with the model group, and "\#" indicates a significant difference compared with the control group. ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, ^∗∗∗^*p* \< 0.001, ^\#^*p* \< 0.05, and ^\#\#\#^*p* \< 0.001. Relative abundance of microbial species in phylum level. Relative abundance of microbial species in Family level.](fphar-09-00639-g005){#F5}

The relation between the structure of intestinal bacterial flora and IBD has been widely investigated. A decrease of Firmicutes and an increase of Proteobacteria were observed in a IBD patient ([@B18]). Moreover, a low level of Actinobacteria has been observed in children with IBD (Sjoberg et al., 2017). Therefore, we investigated the effects of WEAV and VOAV treatment on gut microbiota.

Relative abundances in the level of phylum showed that (**Figure [6A](#F6){ref-type="fig"}**), dominant phylum across all samples included Firmicutes (41.6--58.5%), Bacteroidetes (32.4--51.6%), Proteobacteria (1.5--5.3%) and Actinobacteria (0.25--2.4%). In the MOD group, the sum of abundances of Firmicutes and Bacteroidetes decreased from 95.18 to 81.62%, while the abundance of Spirochaetes increased from 0.06 to 14.5%. In a study conducted by Helbling et al., one pediatric case was reported. The most prominent clinical manifestations of intestinal spirochetosis in children included abdominal pain, diarrhea, and rectal bleeding, which were similar to the characteristics of IBD ([@B30]). In our study, we showed that treatment with VOAV (VOAV.H) and WEAV (WEAV.M) significantly increased the relative abundance of Firmicutes and Bacteroidetes, while a decrease in Proteobacteria was found. In addition, WEAV.M treatment showed a selective enrichment of Cyanobacteria (2.5%), while VOAV.H, VOAV.L, and WEAV.H treatment only affected Actinobacteria at the level of 2.0, 2.0, and 2.5%, respectively. These results were similar to the findings reported by [@B35].

![*Amomum villosum* and regulation of the balance of the intestinal microbial community. Three stool samples were randomly chosen, bar charts showing the relative abundance of the microbial community in phylum **(A)** and family level **(B)** in different stool samples.](fphar-09-00639-g006){#F6}

At the family level, the abundance of Prevotellaceae, Ruminococcaceae, Erysipelotricnaceae, and Peptostrepto-coccaceae in rats in the MOD group was 50% lower compared to that of rats in CON group, while the abundance of Spirochaetaceae reached 14.5% (**Figure [6B](#F6){ref-type="fig"}**). Both VOAV and WEAV treatment had a significantly modulating effect on the above-mentioned bacteria. Among them, VOAV.H and WEAV.L increased the abundance of Prevotellaceae to 24.5 and 21.9%, respectively. The abundance of Ruminococcaceae was increased to about 12.7% in both VOAV.M- and WEAV.M-treated rats, which is similar to that of rats in the CON group.

Influence on Species Highly Associated With Pathogenesis of IBD
---------------------------------------------------------------

The results of the present study suggested that, low abundance of potentially anti-inflammatory microbes were closely related to the incidence of IBD ([@B18]; Sjoberg et al., 2017). At the genus level, the relative abundance of *Prevotella*, *Alloprevotella*, *Clostridium*, *Romboutsia*, and *Bacteroides* in the MOD group was low (0.78, 1.97, 0.32, 1.65, and 1.26%, respectively), compared with the CON group (6.71, 5.89, 0.77, 7.32, and 3.14%) (**Figure [7](#F7){ref-type="fig"}**). VOAV.H treatment affected *Romboutsia* and *Lactobacillus*, as their relative abundance increased to 7.14 and 19.1%. The abundance of *Prevotella* and *Clostridium* in VOAV.M-treated rats were 6.6 and 7.0%, respectively. WEAV.M treatment increased the abundance of *Prevotella* and *Alloprevotella* to 7.14 and 19.1%. In addition, WEAV.H treatment increased the abundance of Prevotella to 7.5%. The percentage of several genera including *Lactobacillus*, *Allobaculum*, and *Ruminococcaceae* was increased by VOAV.H, while *Blautia* levels were only increased by WEAV.H treatment. Enrichment of the short-chain fatty acid producers *Lactobacillus*, *Allobaculum*, *Ruminococcaceae*, and *Blautia* significantly protected pathogen-induced mucosal damage.

![*Amomum villosum* and regulation of the intestinal microbial community. Three stool samples were randomly chosen, bar charts showing the proportions of the relative abundance of the microbial community at the genus level in different stool samples.](fphar-09-00639-g007){#F7}

Analysis of Cluster Heat Map
----------------------------

According to the species annotations and the abundance information at the level of genus, heat maps of the 35 most predictive operational taxonomic units (OTUs) belonging to the genus were plotted, and cluster analysis was conducted (**Figure [8](#F8){ref-type="fig"}**). All experimental groups were divided into three categories: The MOD group was clustered into a single unit; VOAV.H, VOAV.M, and CON groups were clustered into one unit; and WEAV, VOAV.L, and MES groups were clustered in another group. Based on our findings, it may be concluded that VOAV treatment corrected intestinal flora disturbance to normal levels, and that WEAV-treated rats had similar intestinal flora regulating effect compared to rats in the MES-treated group.

![Cluster heat map analysis of the 35 most predictive operational taxonomic units (OTUs) belonging to the genus. Three stool samples were randomly chosen, Heat map represented by color ranging from blue, negative correlation (--2) to red, positive correlation (2). Abscissa axis represented sample information and vertical axis represents annotation information for species. The clustering tree on the left side indicates species clustering, on the top, sample clustering is shown. The values of the hot spot in the center represent *Z* values, which are standardized per species abundance per line.](fphar-09-00639-g008){#F8}

Correlation Between 35 Key Operational Taxonomic Units and Related Indexes
--------------------------------------------------------------------------

Pearson correlation analysis was carried out based on clean data of the OTUs. As shown in **Figure [9](#F9){ref-type="fig"}**, a total of 35 key OTUs were identified and correlated to pharmacological indexes, such as LPS, IL-17, IFN-γ, IL-10, TNF-α, TGF-β, MPO, Foxp3^+^, colon weight, and colon length. Among them, Lachnospiraceae, Erysipelotricnaceae, Ruminococcaceae, Bacteroidaceae, and Prevotellaceae positively correlated with levels of IL-10, TGF-β, and Foxp3^+^. In addition, most Lachnospiraceae, Erysipelotricnaceae, Acidaminococcaceae, Clostridiaceae, and Peptostreptococcaceae negatively correlated with levels of LPS, IL-17, IFN-γ, and MPO activity. Nevertheless, most Lactobacillaceae negatively correlated with IL-10, whereas Helicobacteraceae positively correlated with Foxp3^+^. In addition, a portion of Bacteroidales_S24-7 negatively correlated with TNF-a levels and positively correlated with LPS. Among this family, the abundance of Erysipelotricnaceae, Ruminococcaceae, and Prevotellaceae was markedly increased after administration of *A. villosum*, indicating disturbance of intestinal flora combined with an abnormal immunoregulatory response in IBD development.

![Correlation between 35 key operational taxonomic units (OTUs) and related indexes in rat. Data are expressed as the mean ± SD (*n* = 3). Correlation between the represented bacteria taxa information (genus, family, and phylum) of 35 key OTUs and related indexes in IBD rats. Pearson product moment correlation coefficients are represented by color, ranging from blue, negative correlation (--0.4) to red, positive correlation (0.4). Significant correlations after *P*-value adjustment are marked by ^∗^*p* \< 0.05 and ^∗∗^*p* \< 0.01.](fphar-09-00639-g009){#F9}

Discussion
==========

Trinitrobenzenesulfonic acid-induced IBD has been demonstrated as an ideal rat model for experimental studies on IBD given that it shares several clinical, histological, and immunological features with human CD disease. Ethanol (50%) damaged the gut mucosal barrier, whereas TNBS, acting as a hapten, induced a local mucosal immune response ([@B22]). The colon of TNBS-treated rats adhered with adjacent organs, causing a significant effect on colon weight and length ([@B21]). In the present study, we showed that VOAV and WEAV significantly improved general physiological features of IBD rats, such as body weight gain, food intake recovery, colon length, colon weight, and DAI scores. Treatment effects also included significantly ameliorated macroscopic and microscopic lesions of colons in TNBS-induced IBD rats.

Gut microbiota and an aberrant immune response are among the most accepted hypothesis of IBD pathogenesis. Accumulating evidence has indicated that T lymphocytes play a significant role in the immunological mechanisms of IBD. This was associated with an impaired immune response characterized by an imbalance between CD4^+^ Th cells and regulatory CD4^+^ T cells, which has been reported to regulate pro/anti-inflammatory cytokine production. Foxp3^+^ acts as a specific marker of Tregs and promotes the transition of naïve CD4^+^ T cells to responding CD4^+^ cells ([@B16]). To a certain degree, Tregs inhibited Th1, Th2, and Th17, maintained intestinal homeostasis, and accelerated the repair of the tissue ([@B15]). Th1/Th17 cells that produced IFN-γ and IL-17 induced inflammation, whereas Th2/Treg cells that produced TGF-β and IL-10 expressed Foxp3 and exerted anti-inflammatory activity ([@B32]).

A change in the cytokine profile from Th1 and Th17 to Th2 and Treg could ameliorate the progression of TNBS-induced colitis. Foxp3 dominates Treg formation and production of regulatory cytokines, such as TGF-β and IL-10. In our study, we showed that Th1/Th17 related cytokines, such as IFN-γ and IL-17 were markedly increased in rats in the MOD group, while the production of Th2/Treg associated cytokines TGF-β and IL-10 were reduces during the progression of colitis. Our results showed that the treatment with *A. villosum* could significantly upregulated cytokine levels of TGF-β and IL-10 and downregulated the level of IFN-γ. Using flow cytometry, we observed that the percentage of CD4^+^CD25^+^Foxp3^+^ Treg cells in the WEAV-treated IBD group were significantly higher than other groups.

LPS not only undermined the gut mucosal integrity but also promoted the intestinal lumen pathogenic agents into the bloodstream. In our study, we showed that treatment with *A. villosum* significantly inhibited LPS from entering the blood circulation. This inhibitory effect may be associated with the beneficial effects on the intestinal microflora equilibrium.

Considerable literature shows that more than 90% of all the bacterial species in the human gut belong to the *Bacteroidetes* and *Firmicutes* phyla, followed by lower proportions of *Proteobacteria* and *Actinobacteria* phyla ([@B6]). A decreased bacterial diversity and a greater bacterial instability have been found in patients suffering from IBD. Kang's group reported that some bacteria belonging to the *Firmicutes* phylum including *Eubacterium rectale* of the Lachnospiraceae and *Ruminococcus albus*, *R. callidus*, *R. bromii*, and *F. prausnitzii* of the Ruminococcaceae were 5- to 10-fold more abundant in healthy persons compared to CD ([@B17]). A depletion of *Bacteroides* ([@B24]) and increases in bacteria belonging to the *Proteobacteria* ([@B8]) phyla have been observed in IBD patients. Our results were similar with the findings.

New insights indicated that symbiotic bacteria play an important role in calibrating the balance between intestinal flora and the immune response as colonization with segmented filamentous bacteria (SFB) and Clostridia induced Th17 and Treg cell differentiation in the intestine, respectively([@B1]). Moreover, transferring feces from a healthy donor into the intestinal tract of a patient with IBD helps to recreate a favorable intestinal environment. Short-chain fatty acids (SCFA), as a main source energy in colonic epithelia, were very effective in upregulating the expression of Foxp3^+^, thereby protecting the mucosa from pathogen-induced damage, resulting in mitigating inflammation ([@B34]).

In our study, the Pearson correlation analysis confirmed that disturbance of the intestinal flora was closely related to the abnormal immunoregulation. Our results showed that Firmicutes and Bacteroidetes positively related to IL-10, TGF-β, and Foxp3^+^, whereas a negative correlation was found with IL-17, IFN-γ, MPO, and LPS. *Bacteroides*, *Prevotella*, and *Ruminococcus* that were largely accumulated in the gut microbiota of healthy human subjects had beneficial effects on the immune system ([@B9]). Administration of *A. villosum* significantly increased *Lactobacillus*, *Clostridiu*, *Ruminococcaceae*, *Lachnospiraceae*, *Bacteroides*, and *Prevotella*. Moreover, *A. villosum* decreased the abundance of Proteobacteria, such as *Desulfovibrio*, *Sutterella*, and *Helicobacter*. *A. villosum* also effectively increased SCFA-producing bacteria, thereby modulating the imbalance of intestinal flora.

Aqueous decoction is a traditional and widely used extraction method of traditional Chinese Medicine in clinic. Several investigations have shown that flavonoids, polysaccharide and organic acids are the main chemical composition of WEAV ([@B13]). Flavonoids are known to be effective antimicrobial substances against a wide array of microorganisms ([@B19]). Certain members of flavonoids including flavone and flavonol glycosides, isoflavones have shown the strongest antibacterial activity ([@B5]), and significantly effect the function of the immune system and inflammatory cells (Tunon et al., 2009). Jeff's group define innate immune responses induced by the polysaccharide component of Acai and have implications for the treatment of asthma and infectious disease ([@B12]). Polysaccharides from Rhizome of *Polygonatum odoratum* showed antimicrobial activity against pathogenic bacteria *Staphylococcus aureus*, *Pseudomonas aeruginosa*, *Bacillus subtilis*, and *Escherichia coli* ([@B3]). Organic acid exhibited an inhibitory effect on the growth of a broad range of bacteria including growth of several important pathogens at high concentrations ([@B37]). The regulation effect of WEAV on the regulatory CD4^+^ cells and gut microbiota maybe related with these manifold physiological activators.

In our previous study, bornyl acetate (54.54%) was considered as the main active ingredient of the volatile oil and that it exerts its ant-inflammatory effect via modulation of p38 MAPK kinase and Caspase 3 expression, this could be an explanation for the observed effects in this study ([@B43]). The results were the same as those reported in literatures ([@B42]). Both kind of extracts (volatile and water extracts) showed different therapeutic effects. VOAV had an obvious inhibiting effects on inflammation, but the percentage of CD4^+^CD25^+^Foxp3^+^ Treg cells in the WEAV-treated IBD group were significantly higher than VOAV. High doses of VOAV and WEAV were able to increasing the diversity of dominant bacteria and inhibiting the activity of pathogenetic microbes.

Based on our studies and analysis of the relevant data, we speculated that the bioactivity of *A. villosum* was mediated by the synergistic effects of bornyl acetate, flavonoids, polysaccharide, and organic acids. This was concide with that Chinese medicinal herbs exert their pharmacological effects through a multi-component and multi-target way.

Conclusion
==========

In summary, *A. villosum* effectively relieved IBD by reversing the loss in body weight, and be decreasing the extent of the diarrhea and DAI scores. The expression level of pro-inflammatory cytokines, such as TNF-a, was significantly reduced by *A. villosum* therapy. *A. villosum* not only regulated Th1/Th2 and Th17/Treg-related cytokine production, but also promoted CD4^+^CD25^+^Foxp3^+^ Treg production. So we conclude that the therapeutic effect of *A. villosum* on IBD might be explained by its capability to induce Treg cells and rebalance CD4^+^ T cell subsets. Moreover, *A. villosum* may play a role in maintaining the internal environment by balancing the ratio between Firmicutes, Bacteroidetes, and Proteobacteria, thereby decreasing several opportunistic pathogens related to IBD and increasing SCFA-producing bacteria. In addition, endotoxemia in IBD rats was alleviated by *A. villosum*. Based on the above findings, *A. villosum* is effective in protecting against acute TNBS-induced colitis. Therefore, we conclude that the therapeutic of *A. villosum* on IBD probably connected with increasing the diversity of dominant bacteria, inhibiting the activity of pathogenetic microbes, maintaining the balance of intestinal microecology, promoting Treg differentiation and function, rebalancing CD4^+^ T cell subsets and alleviating intestinal inflammation. However, more profound researches about more detailed molecular mechanism are still needed in our future study.
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